Unilever risks becoming a takeover target as it pursues GSK's consumer healthcare arm

Unilever’s £50bn offer for the consumer healthcare arm of GlaxoSmithKline (GSK) has been rejected – but this feels like the start of what could turn out to be a protracted takeover battle.
Source: Sky Business News